<DOC>
	<DOCNO>NCT02745041</DOCNO>
	<brief_summary>- Haemorrhage severe trauma significant cause mortality potentially preventable cause death trauma patient - Trauma Induced Coagulopathy ( TIC ) complex coagulopathy associate severe trauma - Hypo/dysfibrinogenaemia play important role TIC - Early replacement fibrinogen may improve outcome - Fibrinogen replacement potentially inadequate standard fix ratio Major Haemorrhage Protocols ( MHP ) utilise Plasma and/or Cryoprecipitate - The majority centre utilise cryoprecipitate additional fibrinogen supplementation part MHP - Cryoprecipitate administration often delay ( 60 - 120 minute ) fix ratio MHP - It clear early intervention severe traumatic haemorrhage associate improve outcome - CRASH 2 PROPPR study - Increasing interest use Fibrinogen Concentrate ( FC ) severe bleed support high level evidence - Benefits FC - viral inactivation , know dose , easily reconstitute , administer quickly high dose store room temperature trauma resuscitation bay - No previous study compare FC Cryoprecipitate bleed trauma patient - Fibrinogen supplementation guide accepted ROTEM target treatment algorithm - It pilot , multi-centre randomise control trial compare FC Cryoprecipitate ( current standard practise fibrinogen supplementation ) - Hypothesis : Fibrinogen replacement severe traumatic haemorrhage achieve quicker predictable dose response use Fibrinogen Concentrate compare Cryoprecipitate - It imperative robust clinically relevant trial perform investigate fibrinogen supplementation trauma widespread adoption make perform study unfeasible</brief_summary>
	<brief_title>Fibrinogen Early In Severe Trauma studY</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>1 . Adult affect Trauma ( &gt; 18yrs ) 2 . Judged significant haemorrhage 3 . Predicted require significant transfusion ABC Score â‰¥ 2 treat clinician judgement 1 . Injury judge incompatible survival 2 . Pregnancy 3 . Known objection blood product 4 . Previous Fibrinogen replacement admission 5 . PreTrauma Centre fibrinogen replacement 6 . Participation compete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Fibrinogen</keyword>
	<keyword>Cryoprecipitate</keyword>
</DOC>